BioProcess International Europe is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Alison Mason
Head of Upstream Development at Ipsen Biopharm


Alison joined IPSEN as Head of Upstream Development in 2018 and has around 20 years’ industrial experience, working previously at MedImmune and Lonza Biologics. Her work experience covers both microbial and mammalian expression to develop products from Neurotoxins to Monoclonal Antibodies. Alison’s expertise lies in development of platform processes to facilitate product progress through the clinical pipeline and to simplify and streamline technology transfer and scale-up. She is also interested in cellular metabolism, implementation of high throughput scale-down bioreactors and improved process monitoring. Alison holds a BSc(Hons) in Microbiology from the University of Manchester. 

Alison Mason's Network

Agenda Sessions

  • From Bench To Production: Addressing The Challenges Of Process Development For Novel Highly Potent Therapeutics